INT330877

Context Info Confidence 0.00 First Reported 2010 Last Reported 2010 Negated 1 Speculated 0 Reported most in Body Documents 1 Total Number 1 Disease Relevance 0.08 Pain Relevance 0

cytoplasm (PLDN, Gins4) pigmentation (PLDN) cytosol (PLDN) endosome (PLDN) nucleus (Gins4)

PLDN (Homo sapiens) Gins4 (Rattus norvegicus)

Pain Link Frequency Relevance Heat Eae 6 43.60 depression 1 32.24 Pain 1 25.36 Neurotransmitter 2 5.00 gABA 1 5.00 withdrawal 1 5.00 anesthesia 1 5.00 Glutamate 1 5.00 Catecholamine 1 5.00

Disease Link Frequency Relevance Heat Shock 8 84.80 Amnesia 12 50.00 Depression 1 32.24 Pain 1 25.36 Toxicity 3 19.04 Disease 13 5.00 Cognitive Disorder 9 5.00 Disorder Of Lipid Metabolism 7 5.00 Dementia 2 5.00 Decapitation 2 5.00

Sentences Mentioned In

Key:

Protein

Mutation

Event

Anatomy

Negation

Speculation

Pain term

Disease term

However, in the AT, PA at the dose levels 150 and 300 mg/kg p.o. increased SLD, which is comparable to standard piracetam, but failed to exhibit a significant change when compared with the scopolamine control after 14 days of administration.

PA Neg (failed) Positive_regulation (increased) of SLD

1) Confidence 0.00 Published 2010 Journal Indian Journal of Pharmacology Section Body Doc Link PMC2937319 Disease Relevance 0.08 Pain Relevance 0

General Comments

This test has worked.